Trial Profile
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, 2-Part Study of JNJ-39758979 in Symptomatic Adult Subjects With Uncontrolled, Persistent Asthma.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 18 May 2012
Price :
$35
*
At a glance
- Drugs JNJ 39758979 (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 11 May 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 19 Dec 2011 New trial record